-
1 Comment
NanHua Bio-medicine Co., Ltd is currently in a long term uptrend where the price is trading 43.7% above its 200 day moving average.
From a valuation standpoint, the stock is 122.2% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 21.4.
NanHua Bio-medicine Co., Ltd's total revenue rose by 61.4% to $71M since the same quarter in the previous year.
Its net income has dropped by 70.0% to $12M since the same quarter in the previous year.
Finally, its free cash flow fell by 1229.1% to $-204M since the same quarter in the previous year.
Based on the above factors, NanHua Bio-medicine Co., Ltd gets an overall score of 2/5.
| Exchange | SHE |
|---|---|
| CurrencyCode | CNY |
| ISIN | CNE000000263 |
| Sector | Healthcare |
| Industry | Biotechnology |
| Beta | 0.81 |
|---|---|
| Market Cap | 2B |
| PE Ratio | None |
| Target Price | None |
| Dividend Yield | None |
Landfar Bio-medicine Co., Ltd operates as a biomedical technology company. The company operates through Biomedicine, and Energy Saving and Environmental Protection segments. The Biomedicine segment engages in the provision of stem cell storage and technical services; stem cell therapy research; medical device procurement and sales, etc. The Energy Saving and Environmental Protection segment is involved in the external energy management contract energy management business; build-transfer business and sales of related products; and sewage treatment business. The company was founded in 1991 and is based in Changsha, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 000504.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
